Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma

Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma

Non-melanoma skin cancers are one of the most common cancers diagnosed worldwide, with the highest incidence in Australia and New Zealand. Systemic treatment of locally advanced and metastatic cutaneous squamous cell carcinomas has been revolutionized by immune checkpoint inhibition with PD-1 blocka...

Full description

Bibliographic Details
Main Authors: Annette M. Lim, Karda Cavanagh, Rodney J. Hicks, Luke McLean, Michelle S. Goh, Angela Webb, Danny Rischin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
PD-1 inhibition
pseudoprogression
cutaneous squamous carcinoma
second primary tumors (SPTs)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.656611/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.656611/full

Similar Items